Cited by 79Medication Adherence and ComplianceDiabetes Management and EducationDiabetes Treatment and Management

Defining the role of medication adherence in poor glycemic control among a general adult population with diabetes

Open access
Feldman, Becca S., Cohen-Stavi, Chandra J., Leibowitz, Morton, Hoshen, Moshe B., Singer, Shepherd R., Bitterman, Haim, Lieberman, Nicky, Balicer, Ran D.·2014·PLoS ONE

Abstract

AIMS: This study assesses the attributable impact of adherence to oral glucose medications as a risk factor for poor glycemic control in population subgroups of a large general population, using an objective medication adherence measure. METHODS: Using electronic health records data, adherence to diabetes medications over a two-year period was calculated by prescription-based Medication Possession Ratios for adults with diabetes diagnosed before January 1, 2010. Glycemic control was determined by the HbA1c test closest to the last drug prescription during 2010-2012. Poor control was defined as HbA1c>75 mmol/mol (9.0%). Medication adherence was categorized as "good" (>80%), "moderate" (50-80%), or "poor" (<50%). Logistic regression models assessed the role medication adherence plays in the association between disease duration, age, and poor glycemic control. We calculated the change in the attributable fraction of glucose control if the non-adherent diabetic medication population would become adherent by age-groups. RESULTS: Among 228,846 diabetes patients treated by oral antiglycemic medication, 46.4% had good, 28.8% had moderate, and 24.8% had poor adherence. Good adherence rates increased with increasing disease duration, while glycemic control became worse. There was a strong inverse association between adherence level and poor control (OR = 2.50; CI = 2.43-2.58), and adherence was a significant mediator between age and poor control. CONCLUSIONS: A large portion of the diabetes population is reported to have poor adherence to oral diabetes medications, which is strongly associated with poor glycemic control in all disease durations. While poor adherence does not mediate the poorer glycemic control seen in patients with longer-standing disease, it is a significant mediator of poor glycemic control among younger diabetes patients. A greater fraction of poorly controlled younger patients, compared to older patients, could be prevented if at least 80% adherence to their medications was achieved. Therefore, our results suggest that interventions to improve adherence should focus on this younger sub-group.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0108145

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Feldman, B. S., Cohen-Stavi, C. J., Leibowitz, M., Hoshen, M. B., Singer, S. R., Bitterman, H., Lieberman, N., & Balicer, R. D.
Affiliations
  • Clalit Health Services (IL)
  • New York University (US)
  • Israel Ministry of Health (IL)
  • Technion – Israel Institute of Technology (IL)
  • Ben-Gurion University of the Negev (IL)
Corresponding author
  • Feldman, Becca S.
  • Cohen-Stavi, Chandra J.
  • Leibowitz, Morton
  • Hoshen, Moshe B.
  • Singer, Shepherd R.
  • Bitterman, Haim
  • Lieberman, Nicky
  • Balicer, Ran D.
Venue
PLoS ONE
Published
2014-09-26
Volume
9
Issue
9
Pages
e108145
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2117390981
Cited by
79
References
36
Citations by year
2026: 4 · 2025: 3 · 2024: 4 · 2023: 9 · 2022: 9 · 2021: 9 · 2020: 3 · 2019: 9 · 2018: 9 · 2017: 8 · 2016: 9 · 2015: 3
FWCI
6.88
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Clalit Health Services
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
medication adherence, glycemic control, diabetes mellitus, HbA1c, medication possession ratio, disease duration, age differences, attributable fraction, mediation analysis, young adults
MeSH terms
Adult, Aged, Aged, 80 and over, Blood Glucose, Diabetes Mellitus, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged, Risk Factors, Treatment Outcome, Medication Adherence, Young Adult, Public Health Surveillance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review